Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Neoplasms, Plasma Cell 1Neoplasm, Residual 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Leukemia, Plasma Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Chromosome 17 deletion 1Carcinoma, Non-Small-Cell Lung 1

Interventions

blinatumomab 2Carboplatin 2venetoclax 1treosulfan 1flumatinib 1fludarabine phosphate 1anlotinib 1aflutinib 1Whole-Body Irradiation 1Tyrosine Kinase Inhibitors 1Peripheral Blood Stem Cell Transplantation 1Neoadjuvant Therapy 1Maintenance 1Interferon alpha-2 1Inotuzumab Ozogamicin 1Injections 1Immunotherapy 1Drug Therapy 1Docetaxel 1Decitabine 1Cytarabine 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carmustine 1Busulfan 1Bortezomib 1Blood Specimen Collection 1Azacitidine 1Anti-Inflammatory Agents, Non-Steroidal 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasm, Residual × Maintenance × Clear all
NCT01665001 2012-08-17

Personalized Therapy of Precursor Lymphoid Neoplasms

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice

Phase 2 Unknown
200 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡